Expert Review of Gastroenterology & Hepatology

Papers
(The TQCC of Expert Review of Gastroenterology & Hepatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Current epidemiology in hepatocellular carcinoma112
Recent advances of immunotherapy for biliary tract cancer79
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges74
Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?65
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer53
Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a meta-analysis47
Liver injury in severe COVID-19 infection: current insights and challenges45
Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia40
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota40
Chronic liver disease and oxidative stress – a narrative review39
Capsule endoscopy – Recent developments and future directions39
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD36
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma36
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review36
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care36
Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways35
Obeticholic acid for the treatment of nonalcoholic steatohepatitis31
Is there a causal link between psychological disorders and functional gastrointestinal disorders?29
Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians28
Ranson score to stratify severity in Acute Pancreatitis remains valid – Old is gold28
ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review26
Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management25
Cross-talk between immune system and microbiota in COVID-1924
Endoscopic instruments and techniques in endoscopic submucosal dissection for early gastric cancer23
Recurrence of hepatocellular carcinoma following liver transplantation22
Utilizing artificial intelligence in endoscopy: a clinician’s guide22
A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors22
A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration21
Updates in the field of hereditary nonpolyposis colorectal cancer20
Insights and updates on endoscopic papillectomy20
MAFLD in COVID-19 patients: an insidious enemy20
Data sharing during COVID-19 pandemic: what to take away20
Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges20
Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity19
Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?19
The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication ofHelicobacter pyloriinfection18
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD17
An update on the use of immunotherapy in patients with colorectal cancer17
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib17
Clinical impact of sarcopenia assessment in patients with liver cirrhosis17
Dietary therapy for eosinophilic esophagitis: chances and limitations in the clinical practice17
Epigenetics factors in nonalcoholic fatty liver disease16
Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches16
Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications16
Cholangiocarcinoma: new perspectives for new horizons16
Maternal and infant factors that shape neonatal gut colonization by bacteria16
Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis15
Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis15
The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis15
The clinical application of camrelizumab on advanced hepatocellular carcinoma15
Hepatitis B reactivation: diagnosis and management15
Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patient15
Is histological healing a feasible endpoint in ulcerative colitis?14
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?14
A 2020 update on liver transplant for hepatocellular carcinoma14
Dietary interventions for functional abdominal pain disorders in children: a systematic review and meta-analysis14
An overview of interventions for constipation in adults14
Noninvasive diagnostic tools for pediatric NAFLD: where are we now?14
JAK selectivity: more precision less troubles14
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis14
Helicobacter pylori infection treatment in the United States: clinical consequences and costs of eradication treatment failure14
Iron deficiency anemia in IBD: an overlooked comorbidity14
Irritable bowel syndrome and migraine: evidence from Mendelian randomization analysis in the UK Biobank14
Darvadstrocel for the treatment of perianal fistulas in Crohn’s disease14
Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic13
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry13
Updates in association of gastroesophageal reflux disease and dental erosion: systematic review13
Gut microbiota: a target for intervention in obesity13
Liver-spleen axis in nonalcoholic fatty liver disease13
Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis13
Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis13
Patient’s profiling for therapeutic management of inflammatory bowel disease: a tailored approach13
Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease13
Mucosal healing in Crohn’s disease: new insights13
Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration13
Long-term effects of appendectomy in humans: is it the optimal management of appendicitis?12
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients12
Genetics and epigenetics purpose in nonalcoholic fatty liver disease12
Gastroduodenal tuberculosis: a case series and a management focused systematic review12
Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver12
Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis12
Diagnostic yield of endoscopic ultrasound-guided liver biopsy in comparison to percutaneous liver biopsy: a systematic review and meta-analysis12
The role of vitamin D in inflammatory bowel disease: a guide for clinical practice12
Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study12
Targeting the gut layers in Crohn’s disease: mucosal or transmural healing?12
Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: A systematic review and meta-analysis11
Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis11
Managing cognitive symptoms and fatigue in cholestatic liver disease11
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review11
Implementing psychological therapies for gastrointestinal disorders in pediatrics11
The Integrative Human microbiome project: a mile stone in the understanding of the gut microbiome11
Teduglutide for pediatric short bowel syndrome patients11
The vascular endothelial growth factor signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy11
Endoscopic drainage versus percutaneous drainage for the management of infected walled-off necrosis: a comparative analysis11
Telemedicine in gastroenterology in the wake of COVID-1910
Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma10
Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art10
Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies10
Human intestinal parasitic infection: a narrative review on global prevalence and epidemiological insights on preventive, therapeutic and diagnostic strategies for future perspectives10
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis10
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis10
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran9
The use of peripheral blood mononuclear cells in celiac disease diagnosis and treatment9
Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study9
Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices9
COVID-19 in patients with inflammatory bowel disease9
Use of antibiotic prophylaxis is not needed for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cysts: a meta-analysis9
Metabolic disorders and the risk of cholangiocarcinoma9
Hepatitis c virus and chronic kidney disease9
The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease9
Current role of cyanoacrylate glue transcatheter embolization in the treatment of acute nonvariceal gastrointestinal bleeding9
The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury9
Next generation sequencing for biliary tract cancers9
Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma9
Dilemma in post-IBD patients with IBS-D symptoms: A 2020 overview9
Liver transplant for alcoholic hepatitis: a current clinical overview9
The influence of the gastrointestinal microbiome on infant colic9
Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests9
0.038862943649292